COMMUNIQUÉS West-GlobeNewswire

Tyme Technologies Announces Closing of Public Offering of Common Stock

08/03/2018 - 14:00

NEW YORK, March 08, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME ) (“Tyme” or the “Company”) announced today that, on March 6, 2018, it closed its underwritten public offering of 9,000,000 shares of [...]

Ogilvy CommonHealth Worldwide’s WLPN sponsors six rising stars to join the 2018 HBA Mentoring Program

08/03/2018 - 14:00

PARSIPPANY, N.J., March 08, 2018 (GLOBE NEWSWIRE) -- Ogilvy CommonHealth Worldwide ( www.ogilvychww.com ), a WPP Health & Wellness company (NYSE: WPP ) ( www.wpp.com ), today announced that the network’s Nina [...]

UroGen Pharma to Report Fourth Quarter and Full Year 2017 Financial Results on Thursday, March 15, 2018

08/03/2018 - 14:00

Conference Call and Webcast Scheduled for 8:30 AM ET RA’ANANA, Israel and NEW YORK, March 08, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (NASDAQ: URGN ) today announced that it will report fourth quarter and full year [...]

Gemphire to Present at Two Investor Conferences

08/03/2018 - 14:00

LIVONIA, Mich., March 08, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP ), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders [...]

Dermira to Present at Cowen & Company 38th Annual Healthcare Conference

08/03/2018 - 14:00

MENLO PARK, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM ), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new [...]

BioSyent Schedules Fourth Quarter 2017 Earnings Release for March 21, 2018

08/03/2018 - 14:00

TORONTO, March 08, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”) (TSX Venture:RX) will be reporting its financial results for the fourth quarter and fiscal year ended December 31, 2017 on Wednesday [...]

Caladrius Biosciences Reports Interim Analysis for Phase 2 T-Rex Trial of CLBS03 for Type 1 Diabetes

08/03/2018 - 14:00

BASKING RIDGE, N.J., March 08, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS ) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms [...]

Golden Announces New Line of Cannabis Infused Fruit Chews

08/03/2018 - 14:00

PORTLAND, Ore., March 08, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company built around recognized brands, today announced the [...]

Ultragenyx to Present at Upcoming Investor Conferences

08/03/2018 - 14:00

NOVATO, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE ), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, will present [...]

Dova Pharmaceuticals to Present at Cowen 38th Annual Health Care Conference

08/03/2018 - 14:00

DURHAM, N.C., March 08, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA ) today announced that Alex Sapir, President and Chief Executive Officer, will present a company overview at the Cowen 38 th [...]

Molecular Templates to Present at the Cowen and Company 38th Annual Health Care Conference

08/03/2018 - 14:00

AUSTIN, Texas, March 08, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (Nasdaq: MTEM ) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies (ETBs), a new [...]

HempAmericana to Uplist Shares as Company Seeks to Dominate the $2.1B CBD Oil Market

08/03/2018 - 14:00

NEW YORK, March 08, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- HempAmericana, Inc. (OTC:HMPQ) (“HempAmericana” or the “Company”) is excited to announce that it has begun the process of uplisting the Company’s trading [...]

Interpace Diagnostics Announces Additional Coverage of Thyroid Tests

08/03/2018 - 14:00

PARSIPPANY, N.J., March 08, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG ) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that provides clinically [...]

Aeglea BioTherapeutics Doses First Uveal and Cutaneous Melanoma Patients in Phase 1 Cohort Expansions with Pegzilarginase

08/03/2018 - 14:00

AUSTIN, Texas, March 08, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE ), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with [...]

Selecta Biosciences to Report Fourth Quarter and Year End 2017 Financial Results on Thursday, March 15, 2018

08/03/2018 - 14:00

WATERTOWN, Mass., March 08, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB ), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by avoiding [...]

Progenics Pharmaceuticals Announces Fourth Quarter and Full-Year 2017 Financial Results and Business Update

08/03/2018 - 13:45

Company Preparing for Potential Commercial Launch of AZEDRA® (iobenguane I 131) Ahead of U.S. Food and Drug Administration (FDA) April 30th Action Date Enrollment Complete in Phase 3 Trial for PSMA-Targeted SPECT/CT [...]

Innate Pharma Hosts R&D Day Today in London

08/03/2018 - 13:31

Innate Pharma Hosts R&D Day Today in London Innate Pharma presents a clinical update on its broad and diverse development portfolio of first- or best-in-class antibodies in immuno-oncology Update on the development [...]

Présentation R&D d'Innate Pharma ce jour à Londres

08/03/2018 - 13:31

Présentation R&D d'Innate Pharma ce jour à Londres Innate Pharma présente les avancées cliniques de son portefeuille d'anticorps innovants et diversifié en immuno-oncologie Mise à jour du programme de développement [...]

Marinus Pharmaceuticals to Present at the Barclays Global Healthcare Conference

08/03/2018 - 13:30

RADNOR, Pa., March 08, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS ), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric [...]